116 related articles for article (PubMed ID: 37624590)
1. Biomarker Discovery for Early Diagnosis of Papillary Thyroid Carcinoma Using High-Throughput Enhanced Quantitative Plasma Proteomics.
Lu H; Pan Y; Ruan Y; Zhu C; Hassan HM; Gao J; Gao J; Fan L; Liang X; Wang H; Ying S; Chen Q
J Proteome Res; 2023 Oct; 22(10):3200-3212. PubMed ID: 37624590
[TBL] [Abstract][Full Text] [Related]
2. [Expression and significance of serum E-cadherin in patients with papillary thyroid carcinoma].
Sun L; Wang DM; Zhang WJ; Zhang J; Wu JF
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jan; 31(2):123-126. PubMed ID: 29871201
[No Abstract] [Full Text] [Related]
3. Preoperative platelet distribution width-to-platelet ratio combined with serum thyroglobulin may be objective and popularizable indicators in predicting papillary thyroid carcinoma.
Jin J; Wu G; Ruan C; Ling H; Zheng X; Ying C; Zhang Y
J Clin Lab Anal; 2022 Jun; 36(6):e24443. PubMed ID: 35441746
[TBL] [Abstract][Full Text] [Related]
4. A three plasma microRNA signature for papillary thyroid carcinoma diagnosis in Chinese patients.
Wang Z; Lv J; Zou X; Huang Z; Zhang H; Liu Q; Jiang L; Zhou X; Zhu W
Gene; 2019 Apr; 693():37-45. PubMed ID: 30684524
[TBL] [Abstract][Full Text] [Related]
5. Complement C4-A and Plasminogen as Potential Biomarkers for Prediction of Papillary Thyroid Carcinoma.
Wang Y; Zhou S; Wang D; Wei T; Zhu J; Li Z
Front Endocrinol (Lausanne); 2021; 12():737638. PubMed ID: 34803909
[TBL] [Abstract][Full Text] [Related]
6. Deciphering novel biomarkers of lymph node metastasis of thyroid papillary microcarcinoma using proteomic analysis of ultrasound-guided fine-needle aspiration biopsy samples.
Lin P; Yao Z; Sun Y; Li W; Liu Y; Liang K; Liu Y; Qin J; Hou X; Chen L
J Proteomics; 2019 Jul; 204():103414. PubMed ID: 31195151
[TBL] [Abstract][Full Text] [Related]
7. Plasma-Derived miRNA-222 as a Candidate Marker for Papillary Thyroid Cancer.
Kondrotienė A; Daukša A; Pamedytytė D; Kazokaitė M; Žvirblienė A; Daukšienė D; Simanavičienė V; Klimaitė R; Golubickaitė I; Stakaitis R; Šarauskas V; Verkauskienė R; Žilaitienė B
Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32899424
[TBL] [Abstract][Full Text] [Related]
8. T1 mapping and reduced field-of-view DWI at 3.0 T MRI for differentiation of thyroid papillary carcinoma from nodular goiter.
Yuan L; Zhao P; Lin X; Yu T; Diao R; Ning G
Clin Physiol Funct Imaging; 2023 May; 43(3):137-145. PubMed ID: 36440541
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic Value of Serum Cytokeratin 18, Carcinoembryonic Antigen, and Thyroglobulin in Patients with Papillary Thyroid Carcinoma.
Yan G; Zhou Y; Wu H; Xun H
Clin Lab; 2021 Feb; 67(2):. PubMed ID: 33616340
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic Value of Circulating Cell-free DNA in Patients With Papillary Thyroid Cancer.
Klimaite R; Kazokaite M; Kondrotiene A; Dauksiene D; Verkauskiene R; Zilaitiene B; Dauksa A
Anticancer Res; 2022 May; 42(5):2289-2299. PubMed ID: 35489725
[TBL] [Abstract][Full Text] [Related]
11. Metabolomics of papillary thyroid carcinoma tissues: potential biomarkers for diagnosis and promising targets for therapy.
Shang X; Zhong X; Tian X
Tumour Biol; 2016 Aug; 37(8):11163-75. PubMed ID: 26935059
[TBL] [Abstract][Full Text] [Related]
12. A three-microRNA panel in serum as novel biomarker for papillary thyroid carcinoma diagnosis.
Zou X; Gao F; Wang ZY; Zhang H; Liu QX; Jiang L; Zhou X; Zhu W
Chin Med J (Engl); 2020 Nov; 133(21):2543-2551. PubMed ID: 33009019
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive DNA Methylation Profiling Identifies Novel Diagnostic Biomarkers for Thyroid Cancer.
Park JL; Jeon S; Seo EH; Bae DH; Jeong YM; Kim Y; Bae JS; Kim SK; Jung CK; Kim YS
Thyroid; 2020 Feb; 30(2):192-203. PubMed ID: 31797753
[No Abstract] [Full Text] [Related]
14. Circulating miR-25-3p and miR-451a May Be Potential Biomarkers for the Diagnosis of Papillary Thyroid Carcinoma.
Li M; Song Q; Li H; Lou Y; Wang L
PLoS One; 2015; 10(7):e0132403. PubMed ID: 26168287
[TBL] [Abstract][Full Text] [Related]
15. Clinical implications of TPO and AOX1 in pediatric papillary thyroid carcinoma.
Yu Y; Wang S; Zhang X; Xu S; Li Y; Liu Q; Yang Y; Sun N; Liu Y; Zhang J; Guo Y; Ni X
Transl Pediatr; 2021 Apr; 10(4):723-732. PubMed ID: 34012822
[TBL] [Abstract][Full Text] [Related]
16. Different Expression of Erythrocyte Sedimentation Rate and C-reactive Protein in Papillary Thyroid Carcinoma and Nodular Goiter.
Hou X; Jiang L; Chen C; Zhu X; Ge M
Clin Lab; 2015; 61(7):793-9. PubMed ID: 26299079
[TBL] [Abstract][Full Text] [Related]
17. Roles of phosphatidylinositol 3-kinase regulatory subunit alpha, activator protein-1, and programmed cell death 4 in diagnosis of papillary thyroid carcinoma.
Chen X; Wu W; Chen X; Gong X
Tumour Biol; 2016 May; 37(5):6519-26. PubMed ID: 26637226
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-451 as a prognostic marker for diagnosis and lymph node metastasis of papillary thyroid carcinoma.
Zhang M; Wu W; Gao M; Fei Z
Cancer Biomark; 2017 Jul; 19(4):437-445. PubMed ID: 28582849
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic Value of Serum lncRNA HOTAIR Combined with Galectin-3 in Benign and Papillary Thyroid Carcinoma.
Li L; Wang J; Li Z; Qiu S; Cao J; Zhao Y; Huang Z; He J; Luo F; Yang K
Cancer Manag Res; 2021; 13():6517-6525. PubMed ID: 34447269
[TBL] [Abstract][Full Text] [Related]
20. Serum MMP-2 as a potential predictive marker for papillary thyroid carcinoma.
Shi Y; Su C; Hu H; Yan H; Li W; Chen G; Xu D; Du X; Zhang P
PLoS One; 2018; 13(6):e0198896. PubMed ID: 29949618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]